<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" VersionDate="2022/11/21" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">36605410</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2046-1402</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>F1000Research</Title><ISOAbbreviation>F1000Res</ISOAbbreviation></Journal><ArticleTitle>Explaining the unexpected COVID-19 trends and potential impact across Africa.</ArticleTitle><Pagination><StartPage>1177</StartPage><MedlinePgn>1177</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1177</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.12688/f1000research.74363.2</ELocationID><Abstract><AbstractText>Official COVID-19 case counts and mortality rates across Africa are lower than had been anticipated. Research reports, however, indicate far higher exposure rates than the official counts in some countries. Particularly in Western and Central Africa, where mortality rates are disproportionately lower than the rest of the continent, this occurrence may be due to immune response adaptations resulting from (1) frequent exposure to certain pro-inflammatory pathogens, and (2) a prevalence of low-grade inflammation coupled with peculiar modifications to the immune response based on one's immunobiography. We suggest that the two factors lead to a situation where post infection, there is a rapid ramp-up of innate immune responses, enough to induce effective defense and protection against plethora pathogens. Alongside current efforts at procuring and distributing vaccines, we draw attention to the need for work towards appreciating the impact of the apparently widespread, asymptomatic SARS-CoV-2 infections on Africa's populations <i>vis a vis</i> systemic inflammation status and long-term consequences for public health.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2022 Oduro-Mensah D et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oduro-Mensah</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4492-2202</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oduro-Mensah</LastName><ForeName>Ebenezer</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ga-East Municipal Hospital, Ghana Health Service, Accra, WY1895, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quashie</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, LG 581, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awandare</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okine</LastName><ForeName>Laud</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/P028071/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>F1000Res</MedlineTA><NlmUniqueID>101594320</NlmUniqueID><ISSNLinking>2046-1402</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Immunobiography</Keyword><Keyword MajorTopicYN="N">Inflamm-aging</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword></KeywordList><CoiStatement>No competing interests were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>22</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36605410</ArticleId><ArticleId IdType="pmc">PMC9763772</ArticleId><ArticleId IdType="doi">10.12688/f1000research.74363.2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO Coronavirus (COVID-19) Dashboard |WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Accessed November 2, 2022.
https://covid19.who.int/?gclid=CjwKCAjwsfuYBhAZEiwA5a6CDNIkRLbHur-1-U2AQvXAiTtNd2VC3s19tvoSlKU2GD9efUuE-LGO4hoCy-QQAvD_BwE
</Citation></Reference><Reference><Citation>
Germany declares a Covid &#x201c;third wave&#x201d; has begun ; Italy set for Easter lockdown. Accessed March 16, 2021.
https://www.cnbc.com/2021/03/12/germany-declares-a-covid-third-wave-has-begun-italy-set-for-easter-lockdown.html
</Citation></Reference><Reference><Citation>
Europe is struggling to contain the third wave of the epidemic . - CNN. Accessed March 16, 2021.
https://edition.cnn.com/2021/03/15/world/coronavirus-newsletter-03-15-21-int/index.html
</Citation></Reference><Reference><Citation>
Third Covid wave sweeps across EU and forces new restrictions |Coronavirus|The Guardian. Accessed March 16, 2021.
https://www.theguardian.com/world/2021/mar/14/third-covid-wave-sweeps-across-eu-and-forces-new-restrictions
</Citation></Reference><Reference><Citation>
France Battles a Third Wave of COVID Infections |Voice of America - English. Accessed March 16, 2021.
https://www.voanews.com/covid-19-pandemic/france-battles-third-wave-covid-infections
</Citation></Reference><Reference><Citation>
Risk of COVID-19 surge threatens Africa&#x2019;s health facilities |WHO|Regional Office for Africa. Accessed July 4, 2021.
https://www.afro.who.int/news/risk-covid-19-surge-threatens-africas-health-facilities
</Citation></Reference><Reference><Citation>
Africa faces steepest COVID-19 surge yet |WHO|Regional Office for Africa. Accessed July 4, 2021.
https://www.afro.who.int/news/africa-faces-steepest-covid-19-surge-yet
</Citation></Reference><Reference><Citation>Biccard BM, Gopalan PD, Miller M, et al. : Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study. Lancet. 2021;397(10288):1885&#x2013;1894. 10.1016/S0140-6736(21)00441-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00441-4</ArticleId><ArticleId IdType="pmc">PMC8137309</ArticleId><ArticleId IdType="pubmed">34022988</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Population Clock : 7.9 Billion People (2021) - Worldometer. Accessed March 15, 2021.
https://www.worldometers.info/world-population/
</Citation></Reference><Reference><Citation>
Coronavirus deaths by country in Africa 2021 |Statista. Accessed September 12, 2022.
https://www.statista.com/statistics/1170530/coronavirus-deaths-in-africa/
</Citation></Reference><Reference><Citation>Coronavirus Disease 2019 (COVID-19) &#x2013; Africa CDC. Accessed November 2, 2022.
https://africacdc.org/covid-19/
</Citation></Reference><Reference><Citation>
Worldometer - real time world statistics. Accessed November 2, 2022.
https://www.worldometers.info/
</Citation></Reference><Reference><Citation>Napoli PE, Nioi M: Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in the Early Stage of A Pandemic. J Clin Med. 2020;9(4):1138. 10.3390/JCM9041138</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM9041138</ArticleId><ArticleId IdType="pmc">PMC7230338</ArticleId><ArticleId IdType="pubmed">32316118</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbow M, Lell B, Jochems SP, et al. : COVID-19 in Africa: Dampening the storm? Science. 2020;369(6504):624&#x2013;626. 10.1126/SCIENCE.ABD3902</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ABD3902</ArticleId><ArticleId IdType="pubmed">32764055</ArticleId></ArticleIdList></Reference><Reference><Citation>Diop BZ, Ngom M, Biyong CP, et al. : The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study. BMJ Glob. Health. 2020;5(5). 10.1136/BMJGH-2020-002699</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJGH-2020-002699</ArticleId><ArticleId IdType="pmc">PMC7252974</ArticleId><ArticleId IdType="pubmed">32451367</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams J, MacKenzie MJ, Amegah AK, et al. : The Conundrum of Low COVID-19 Mortality Burden in sub-Saharan Africa: Myth or Reality? Glob Health Sci Pract. Published online July 30,2021. 10.9745/GHSP-D-21-00172</Citation><ArticleIdList><ArticleId IdType="doi">10.9745/GHSP-D-21-00172</ArticleId><ArticleId IdType="pmc">PMC8514030</ArticleId><ArticleId IdType="pubmed">34593571</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendrot M, Duflot I, Boxberger M, et al. : Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa. In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate. Published online2020. 10.1016/j.ijid.2020.08.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.08.032</ArticleId><ArticleId IdType="pmc">PMC7426697</ArticleId><ArticleId IdType="pubmed">32805422</ArticleId></ArticleIdList></Reference><Reference><Citation>
Why Africa&#x2019;s COVID-19 Outbreak Isn&#x2019;t So Bad |Time. Accessed March 12, 2021.
https://time.com/5919241/africa-covid-19-outbreak/
</Citation></Reference><Reference><Citation>
Coronavirus in Africa : Five reasons why Covid-19 has been less deadly than elsewhere - BBC News. Accessed March 12, 2021.
https://www.bbc.com/news/world-africa-54418613
</Citation></Reference><Reference><Citation>Njenga MK, Dawa J, Nanyingi M, et al. : Why is there low morbidity and mortality of COVID-19 in Africa? Am J Trop Med Hyg. 2020;103(2):564&#x2013;569. 10.4269/ajtmh.20-0474</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0474</ArticleId><ArticleId IdType="pmc">PMC7410455</ArticleId><ArticleId IdType="pubmed">32484156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tso FY, Lidenge SJ, Pe&#xf1;a PB, et al. : High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa. Int J Infect Dis. 2021;102:577&#x2013;583. 10.1016/J.IJID.2020.10.104</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJID.2020.10.104</ArticleId><ArticleId IdType="pmc">PMC7648883</ArticleId><ArticleId IdType="pubmed">33176202</ArticleId></ArticleIdList></Reference><Reference><Citation>
Why Africa&#x2019;s experience with COVID-19 has been atypical so far . Accessed March 12, 2021.
https://www.nationalgeographic.com/science/article/africa-first-coronavirus-wave-was-atypical-second-surge-could-be-too
</Citation></Reference><Reference><Citation>Kusi KA, Frimpong A, Partey FD, et al. : High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa. AAS Open Res. 2021;4:2. 10.12688/aasopenres.13196.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/aasopenres.13196.1</ArticleId><ArticleId IdType="pmc">PMC8524298</ArticleId><ArticleId IdType="pubmed">34729457</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonte L, Acosta A, Sarmiento ME, et al. : COVID-19 Lethality in Sub-Saharan Africa and Helminth Immune Modulation. Front Immunol. 2020;11:2459. 10.3389/FIMMU.2020.574910</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2020.574910</ArticleId><ArticleId IdType="pmc">PMC7578247</ArticleId><ArticleId IdType="pubmed">33117371</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidoo P, Ghazi T, Chuturgoon AA, et al. : SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective. Environ Int. 2021;156: 106695. 10.1016/J.ENVINT.2021.106695</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ENVINT.2021.106695</ArticleId><ArticleId IdType="pmc">PMC8205275</ArticleId><ArticleId IdType="pubmed">34171587</ArticleId></ArticleIdList></Reference><Reference><Citation>
Malaria cases: estimated country share 2018 |Statista. Accessed July 5, 2021.
https://www.statista.com/statistics/790174/estimated-share-of-total-malaria-cases-by-country/
</Citation></Reference><Reference><Citation>Ademolue TW, Aniweh Y, Kusi KA, et al. : Patterns of inflammatory responses and parasite tolerance vary with malaria transmission intensity. Malar J. 2017;16(1):145. 10.1186/s12936-017-1796-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12936-017-1796-x</ArticleId><ArticleId IdType="pmc">PMC5387356</ArticleId><ArticleId IdType="pubmed">28399920</ArticleId></ArticleIdList></Reference><Reference><Citation>Moncunill G, Mayor A, Jim&#xe9;nez A, et al. : Cytokine and Antibody Responses to Plasmodium falciparum in Na&#xef;ve Individuals during a First Malaria Episode: Effect of Age and Malaria Exposure. Beeson JG, ed. PLoS One. 2013;8(2): e55756. 10.1371/journal.pone.0055756</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055756</ArticleId><ArticleId IdType="pmc">PMC3578867</ArticleId><ArticleId IdType="pubmed">23437061</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagannathan P, Kim CC, Greenhouse B, et al. : Loss and dysfunction of V&#x3b4;2+&#x3b3;&#x3b4; T cells are associated with clinical tolerance to malaria. Sci Transl Med. 2014;6(251): 251ra117. 10.1126/scitranslmed.3009793</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3009793</ArticleId><ArticleId IdType="pmc">PMC4198150</ArticleId><ArticleId IdType="pubmed">25163477</ArticleId></ArticleIdList></Reference><Reference><Citation>Doolan DL, Doba&#xf1;o C, Baird JK: Acquired immunity to Malaria. Clin Microbiol Rev. 2009;22(1):13&#x2013;36. 10.1128/CMR.00025-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00025-08</ArticleId><ArticleId IdType="pmc">PMC2620631</ArticleId><ArticleId IdType="pubmed">19136431</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield L, Mueller I: Clinical Immunity to Malaria. Curr Mol Med. 2006;6(2):205&#x2013;221. 10.2174/156652406776055221</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652406776055221</ArticleId><ArticleId IdType="pubmed">16515511</ArticleId></ArticleIdList></Reference><Reference><Citation>Portugal S, Moebius J, Skinner J, et al. : Exposure-Dependent Control of Malaria-Induced Inflammation in Children. Kazura JW, ed. PLoS Pathog. 2014;10(4): e1004079. 10.1371/journal.ppat.1004079</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004079</ArticleId><ArticleId IdType="pmc">PMC3990727</ArticleId><ArticleId IdType="pubmed">24743880</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrington L, Vance H, Rek J, et al. : Both inflammatory and regulatory cytokine responses to malaria are blunted with increasing age in highly exposed children. Malar J. 2017;16(1):499. 10.1186/s12936-017-2148-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12936-017-2148-6</ArticleId><ArticleId IdType="pmc">PMC5747142</ArticleId><ArticleId IdType="pubmed">29284469</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostr&#xf6;m S, Giusti P, Arama C, et al. : Changes in the levels of cytokines, chemokines and malaria-specific antibodies in response to Plasmodium falciparum infection in children living in sympatry in Mali. Malar J. 2012:11. 10.1186/1475-2875-11-109</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2875-11-109</ArticleId><ArticleId IdType="pmc">PMC3366880</ArticleId><ArticleId IdType="pubmed">22480186</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ombrain MC, Robinson LJ, Stanisic DI, et al. : Association of early interferon-&#x3b3; production with immunity to clinical malaria: A longitudinal study among Papua New Guinean children. Clin Infect Dis. 2008;47(11):1380&#x2013;1387. 10.1086/592971</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/592971</ArticleId><ArticleId IdType="pubmed">18947328</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Dong X, Ma R, et al. : Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020;11(1):1&#x2013;12. 10.1038/s41467-020-17665-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType="pmc">PMC7392898</ArticleId><ArticleId IdType="pubmed">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>
SARS-CoV-2 delays interferon signaling in host cells . Accessed March 12, 2021.
https://www.news-medical.net/news/20210207/SARS-CoV-2-delays-interferon-signaling-in-host-cells.aspx
</Citation></Reference><Reference><Citation>Jiang Hw, Zhang Hn, Meng Qf, et al. : SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70. Cell Mol Immunol. 2020;17(9). 10.1038/s41423-020-0514-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0514-8</ArticleId><ArticleId IdType="pmc">PMC7387808</ArticleId><ArticleId IdType="pubmed">32728199</ArticleId></ArticleIdList></Reference><Reference><Citation>Stertz S, Hale BG: Interferon system deficiencies exacerbating severe pandemic virus infections. Trends Microbiol. Published online.2021:1&#x2013;10. 10.1016/j.tim.2021.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC7980109</ArticleId><ArticleId IdType="pubmed">33757684</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Liu Z, Moncada-Velez M, et al. : Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science (1979). 2020;370(6515). 10.1126/SCIENCE.ABD4570</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ABD4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C, Zhou M, Liu Y, et al. : Characteristics of asymptomatic COVID-19 infection and progression: A multicenter, retrospective study. Virulence. 2020;11(1). 10.1080/21505594.2020.1802194</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2020.1802194</ArticleId><ArticleId IdType="pmc">PMC7550018</ArticleId><ArticleId IdType="pubmed">32722990</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YH, Jin N, Kelly F, et al. : Elevation of alanine aminotransferase activity occurs after activation of the cell-death signaling initiated by pattern-recognition receptors but before activation of cytolytic effectors in NK or CD8+ T cells in the liver during acute HCV infection. PLoS One. 2016;11(10). 10.1371/journal.pone.0165533</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165533</ArticleId><ArticleId IdType="pmc">PMC5082795</ArticleId><ArticleId IdType="pubmed">27788241</ArticleId></ArticleIdList></Reference><Reference><Citation>Trindade Bezerra JM, Soeiro Barbosa D, Rogerl&#xe2;ndio Martins-Melo F, et al. : Changes in malaria patterns in Brazil over 28&#x2009;years (1990&#x2013;2017): results from the Global Burden of Disease Study 2017.Published online2020. 10.1186/s12963-020-00211-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12963-020-00211-6</ArticleId><ArticleId IdType="pmc">PMC7526087</ArticleId><ArticleId IdType="pubmed">32993671</ArticleId></ArticleIdList></Reference><Reference><Citation>
Brazil : number of COVID-19 deaths, by state 2022|Statista. Accessed September 12, 2022.
https://www.statista.com/statistics/1107109/brazil-coronavirus-deaths-state/
</Citation></Reference><Reference><Citation>Hong M, Bertoletti A: Tolerance and immunity to pathogens in early life: insights from HBV infection. Semin Immunopathol. 2017;39(6):643&#x2013;652. 10.1007/s00281-017-0641-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0641-1</ArticleId><ArticleId IdType="pmc">PMC5711997</ArticleId><ArticleId IdType="pubmed">28685270</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap GS, Gause WC: Helminth infections induce tissue tolerance mitigating immunopathology but enhancing microbial pathogen susceptibility. Front Immunol. 2018;9(OCT):2135 10.3389/fimmu.2018.02135</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02135</ArticleId><ArticleId IdType="pmc">PMC6198046</ArticleId><ArticleId IdType="pubmed">30386324</ArticleId></ArticleIdList></Reference><Reference><Citation>King IL, Li Y: Host-parasite interactions promote disease tolerance to intestinal helminth infection. Front Immunol. 2018;9(SEP):2128. 10.3389/fimmu.2018.02128</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02128</ArticleId><ArticleId IdType="pmc">PMC6160735</ArticleId><ArticleId IdType="pubmed">30298071</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Li P, Ji Y, et al. : Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses. Lancet Microbe. 2020;1(4): e151. 10.1016/S2666-5247(20)30098-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30098-7</ArticleId><ArticleId IdType="pmc">PMC7836609</ArticleId><ArticleId IdType="pubmed">33521716</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Wang Y, Kang L, et al. : Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Emerg Microbes Infect. 2021;10(1):664&#x2013;676. 10.1080/22221751.2021.1905488</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1905488</ArticleId><ArticleId IdType="pmc">PMC8023607</ArticleId><ArticleId IdType="pubmed">33734013</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnb&#xe4;ck C, Hansson E: The Importance and Control of Low-Grade Inflammation Due to Damage of Cellular Barrier Systems That May Lead to Systemic Inflammation. Front Neurol. 2019;10(MAY):533. 10.3389/fneur.2019.00533</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00533</ArticleId><ArticleId IdType="pmc">PMC6549124</ArticleId><ArticleId IdType="pubmed">31191433</ArticleId></ArticleIdList></Reference><Reference><Citation>Le&#xf3;n-Pedroza JI, Gonz&#xe1;lez-Tapia LA, Olmo-Gil E, et al. : Low-grade systemic inflammation and the development of metabolic diseases: From the molecular evidence to the clinical practice. Cirug&#xed;a y Cirujanos (English Edition). 2015;83(6):543&#x2013;551. 10.1016/j.circen.2015.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.circen.2015.11.008</ArticleId><ArticleId IdType="pubmed">26159364</ArticleId></ArticleIdList></Reference><Reference><Citation>Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the elderly. Exp Gerontol. 2004;39(5):687&#x2013;699. 10.1016/j.exger.2004.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2004.01.009</ArticleId><ArticleId IdType="pubmed">15130663</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder PC, Bosco N, Bourdet-Sicard R, et al. : Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Res Rev. 2017;40:95&#x2013;119. 10.1016/j.arr.2017.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2017.09.001</ArticleId><ArticleId IdType="pubmed">28899766</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro AM, Macedo-de la Concha LE, Pantoja-Mel&#xe9;ndez CA: Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Revista M&#xe9;dica del Hospital General de M&#xe9;xico. 2017;80(2):101&#x2013;105. 10.1016/j.hgmx.2016.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hgmx.2016.06.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Minihane AM, Vinoy S, Russell WR, et al. : Low-grade inflammation, diet composition and health: Current research evidence and its translation. Br J Nutr. 2015;114(7):999&#x2013;1012. 10.1017/S0007114515002093</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114515002093</ArticleId><ArticleId IdType="pmc">PMC4579563</ArticleId><ArticleId IdType="pubmed">26228057</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Rise and Rise of Chronic Diseases in Africa - Sanofi. Accessed March 14, 2021.
https://www.sanofi.com/en/your-health/the-rise-and-rise-of-chronic-diseases-in-africa
</Citation></Reference><Reference><Citation>
de-Graft Aikins A, Addo J, Ofei F, et al. :
Ghana&#x2019;s burden of chronic non-communicable diseases: future directions in research, practice and policy.

Ghana Med J.

2012;46(2 Suppl):1&#x2013;3. Accessed March 19, 2021.
http://www.globalizationandhealth.com/series
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3645141</ArticleId><ArticleId IdType="pubmed">23661810</ArticleId></ArticleIdList></Reference><Reference><Citation>de-Graft Aikins A, Unwin N, Agyemang C, et al. : Tackling Africa&#x2019;s chronic disease burden: From the local to the global. Global Health. 2010;6. 10.1186/1744-8603-6-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1744-8603-6-5</ArticleId><ArticleId IdType="pmc">PMC2873934</ArticleId><ArticleId IdType="pubmed">20403167</ArticleId></ArticleIdList></Reference><Reference><Citation>Moro-Garc&#xed;a MA, Mayo JC, Sainz RM, et al. : Influence of inflammation in the process of T lymphocyte differentiation: Proliferative, metabolic, and oxidative changes. Front Immunol. 2018;9(MAR):1. 10.3389/fimmu.2018.00339</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00339</ArticleId><ArticleId IdType="pmc">PMC5839096</ArticleId><ArticleId IdType="pubmed">29545794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciornei RT: Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories. Front Immunol. 2020;11:1762. 10.3389/fimmu.2020.01762</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01762</ArticleId><ArticleId IdType="pmc">PMC7372100</ArticleId><ArticleId IdType="pubmed">32760408</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappetta S, Sharma AM, Bottino V, et al. : COVID-19 and the role of chronic inflammation in patients with obesity. Int J Obes. 2020;44(8):1790&#x2013;1792. 10.1038/s41366-020-0597-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-020-0597-4</ArticleId><ArticleId IdType="pmc">PMC7224343</ArticleId><ArticleId IdType="pubmed">32409680</ArticleId></ArticleIdList></Reference><Reference><Citation>Huizinga GP, Singer BH, Singer K: The collision of meta-inflammation and SARS-CoV-2 pandemic infection. Endocrinology (United States). 2020;161(11):1&#x2013;10. 10.1210/endocr/bqaa154</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa154</ArticleId><ArticleId IdType="pmc">PMC7499583</ArticleId><ArticleId IdType="pubmed">32880654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Nam JH: Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection. Int J Obes. 2020;44(7):1541&#x2013;1542. 10.1038/s41366-020-0602-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-020-0602-y</ArticleId><ArticleId IdType="pmc">PMC7243431</ArticleId><ArticleId IdType="pubmed">32444771</ArticleId></ArticleIdList></Reference><Reference><Citation>Tskhay A, Yezhova A, Alibek K. COVID-19 Pandemic: Is Chronic Inflammation a Major Cause of Death? 10.1101/2020.05.12.20099572</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.12.20099572</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar AN, Gilroy DW. Aging immunity may exacerbate COVID-19. Science (1979). 2020;369(6501):256&#x2013;257. 10.1126/science.abb0762</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb0762</ArticleId><ArticleId IdType="pubmed">32675364</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostaghim A, Sinha P, Bielick C, et al. : Clinical outcomes and inflammatory marker levels in patients with Covid-19 and obesity at an inner-city safety net hospital. Zivkovic AR, ed. PLoS One. 2020;15: e0243888. 10.1371/journal.pone.0243888</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243888</ArticleId><ArticleId IdType="pmc">PMC7744045</ArticleId><ArticleId IdType="pubmed">33326480</ArticleId></ArticleIdList></Reference><Reference><Citation>Honce R, Schultz-Cherry S: Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10(MAY):1071. 10.3389/fimmu.2019.01071</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01071</ArticleId><ArticleId IdType="pmc">PMC6523028</ArticleId><ArticleId IdType="pubmed">31134099</ArticleId></ArticleIdList></Reference><Reference><Citation>Green WD, Beck MA: Obesity impairs the adaptive immune response to influenza virus. Ann Am Thorac Soc. 2017;14(Suppl 5):S406&#x2013;S409. 10.1513/AnnalsATS.201706-447AW</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201706-447AW</ArticleId><ArticleId IdType="pmc">PMC5711276</ArticleId><ArticleId IdType="pubmed">29161078</ArticleId></ArticleIdList></Reference><Reference><Citation>Dicker D, Bettini S, Farpour-Lambert N, et al. : Obesity and COVID-19: The Two Sides of the Coin. Obes Facts. 2020;13(4):430&#x2013;438. 10.1159/000510005</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000510005</ArticleId><ArticleId IdType="pmc">PMC7841065</ArticleId><ArticleId IdType="pubmed">32659766</ArticleId></ArticleIdList></Reference><Reference><Citation>Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China A total of 383 consecutively hospitalized patients with COVID.Published online2020. 10.2337/dc20-0576</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0576</ArticleId></ArticleIdList></Reference><Reference><Citation>
Contributor : Links Between COVID-19 Comorbidities, Mortality Detailed in FAIR Health Study. Accessed March 16, 2021.
https://www.ajmc.com/view/contributor-links-between-covid-19-comorbidities-mortality-detailed-in-fair-health-study
</Citation></Reference><Reference><Citation>Gupta R, Agrawal R, Bukhari Z, et al. : Higher comorbidities and early death in hospitalized African-American patients with Covid-19. BMC Infect Dis. 2021;21(1):78. 10.1186/s12879-021-05782-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05782-9</ArticleId><ArticleId IdType="pmc">PMC7812567</ArticleId><ArticleId IdType="pubmed">33461499</ArticleId></ArticleIdList></Reference><Reference><Citation>
Age, sex, comorbidities impact outcomes after COVID-19 hospitalization.Accessed March 16, 2021.
https://www.healio.com/news/cardiology/20210106/age-sex-comorbidities-impact-outcomes-after-covid19-hospitalization
</Citation></Reference><Reference><Citation>D&#x2019;ascanio M, Innammorato M, Pasquariello L, et al. : Age is not the only risk factor in COVID-19: the role of comorbidities and of long staying in residential care homes. BMC Geriatr. 2021;21(1):63. 10.1186/s12877-021-02013-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02013-3</ArticleId><ArticleId IdType="pmc">PMC7809533</ArticleId><ArticleId IdType="pubmed">33451296</ArticleId></ArticleIdList></Reference><Reference><Citation>
Patients with COVID-19 and obesity have poor outcomes not driven by inflammation|EurekAlert! Science News.Accessed March 12, 2021.
https://www.eurekalert.org/pub_releases/2020-12/buso-pwc121620.php
</Citation></Reference><Reference><Citation>Kooistra EJ, Nooijer AH, Claassen WJ, et al. : A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients. Int J Obes. 2021;45(3):687&#x2013;694. 10.1038/s41366-021-00747-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00747-z</ArticleId><ArticleId IdType="pmc">PMC7829495</ArticleId><ArticleId IdType="pubmed">33495522</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizarro-S&#xe1;nchez MS, Avello A, Mas-Fontao S, et al. : Clinical Features of Asymptomatic SARS-CoV-2 Infection in Hemodialysis Patients. Kidney Blood Press Res. 2021;46(1):1&#x2013;9. 10.1159/000512535</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512535</ArticleId><ArticleId IdType="pmc">PMC7900451</ArticleId><ArticleId IdType="pubmed">33503627</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Lewis AM, Moley JR, et al. : A systematic review and meta-analysis of obesity and COVID-19 outcomes. Sci Rep. 2021;11(1):1&#x2013;11. 10.1038/s41598-021-86694-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86694-1</ArticleId><ArticleId IdType="pmc">PMC8009961</ArticleId><ArticleId IdType="pubmed">33785830</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu Y, Yang J, Shi J, et al. : Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):1&#x2013;15. 10.1186/S40001-020-00464-9/FIGURES/5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S40001-020-00464-9/FIGURES/5</ArticleId><ArticleId IdType="pmc">PMC7708895</ArticleId><ArticleId IdType="pubmed">33267871</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Tian C, Chen Y, et al. : Obesity aggravates COVID-19: An updated systematic review and meta-analysis. J Med Virol. 2021;93(5):2662&#x2013;2674. 10.1002/JMV.26677</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.26677</ArticleId><ArticleId IdType="pmc">PMC7753795</ArticleId><ArticleId IdType="pubmed">33200825</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawadogo W, Tsegaye M, Gizaw A, et al. : Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis. BMJ Nutr Prev Health. 2022;0: e000375. 10.1136/BMJNPH-2021-000375</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJNPH-2021-000375</ArticleId><ArticleId IdType="pmc">PMC8783972</ArticleId><ArticleId IdType="pubmed">35814718</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack FP, Thomas SJ, Kitchin N, et al. : Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603&#x2013;2615. 10.1056/nejmoa2034577</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy MN, Minassian AM, Ewer KJ, et al. : Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2020;396(10267):1979&#x2013;1993. 10.1016/S0140-6736(20)32466-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32466-1</ArticleId><ArticleId IdType="pmc">PMC7674972</ArticleId><ArticleId IdType="pubmed">33220855</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson EJ, Rouphael NG, Widge AT, et al. : Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N Engl J Med. 2020;383(25):2427&#x2013;2438. 10.1056/nejmoa2028436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2028436</ArticleId><ArticleId IdType="pmc">PMC7556339</ArticleId><ArticleId IdType="pubmed">32991794</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanada F, Taniyama Y, Muratsu J, et al. : Source of Chronic Inflammation in Aging. Front Cardiovasc Med. 2018;5:12. 10.3389/fcvm.2018.00012</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2018.00012</ArticleId><ArticleId IdType="pmc">PMC5850851</ArticleId><ArticleId IdType="pubmed">29564335</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Campisi J: Chronic inflammation (Inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69:S4&#x2013;S9. 10.1093/gerona/glu057</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glu057</ArticleId><ArticleId IdType="pubmed">24833586</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda A, Qian F, Mohanty S, et al. : Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response. J Immunol. 2010;184(5):2518&#x2013;2527. 10.4049/jimmunol.0901022</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901022</ArticleId><ArticleId IdType="pmc">PMC3867271</ArticleId><ArticleId IdType="pubmed">20100933</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarner V, Rubio-Ruiz ME: Aging and Health-A Systems Biology Perspective. Interdiscipl Top Gerontol Basel, Karger. 2015;40:99&#x2013;106. 10.1159/000364934</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000364934</ArticleId><ArticleId IdType="pubmed">25341516</ArticleId></ArticleIdList></Reference><Reference><Citation>Grignolio A, Mishto M, Caetano Faria AM, et al. : Towards a liquid self: How time, geography, and life experiences reshape the biological identity. Front Immunol. 2014;5(APR):153. 10.3389/fimmu.2014.00153</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00153</ArticleId><ArticleId IdType="pmc">PMC3988364</ArticleId><ArticleId IdType="pubmed">24782860</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvioli S, Monti D, Lanzarini C, et al. : Immune System, Cell Senescence, Aging and Longevity - Inflamm-Aging Reappraised.</Citation><ArticleIdList><ArticleId IdType="pubmed">23589904</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Capri M, Monti D, et al. : Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128(1):92&#x2013;105. 10.1016/j.mad.2006.11.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2006.11.016</ArticleId><ArticleId IdType="pubmed">17116321</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrisette-Thomas V, Cohen AA, F&#xfc;l&#xf6;p T, et al. : Inflamm-aging does not simply reflect increases in pro-inflammatory markers. Mech Ageing Dev. 2014;139(1):49&#x2013;57. 10.1016/j.mad.2014.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2014.06.005</ArticleId><ArticleId IdType="pmc">PMC5881904</ArticleId><ArticleId IdType="pubmed">25011077</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Aetou M, et al. : Clinical course of COVID-19 patients needing supplemental oxygen outside the intensive care unit. Sci Rep. 2021;11(1):2256. 10.1038/s41598-021-81444-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81444-9</ArticleId><ArticleId IdType="pmc">PMC7838409</ArticleId><ArticleId IdType="pubmed">33500431</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H, Asseo K, Karni N, et al. : Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. Clin Microbiol Infect. 2021; (0):1. 10.1016/j.cmi.2021.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.008</ArticleId><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. : Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2020;27(2):258. 10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. : Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144. 10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. : Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: A population-based cohort study. Thorax. Published online December 3, 2020. 10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. : 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. : Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6. 10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, et al. : Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. Published online November 11, 2020. 10.7326/m20-5661</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, et al. : Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasselin J, Magne E, Beau C, et al. : Low-grade inflammation is a major contributor of impaired attentional set shifting in obese subjects. Brain Behav Immun. 2016;58:63&#x2013;68. 10.1016/j.bbi.2016.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.05.013</ArticleId><ArticleId IdType="pubmed">27223095</ArticleId></ArticleIdList></Reference><Reference><Citation>Quashie PK, Mutungi JK, Dzabeng F, et al. : Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana. Wellcome Open Res. 2021;6:173. 10.12688/wellcomeopenres.16890.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16890.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Struck NS, Lorenz E, Deschermeier C, et al. : High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study. BMC Public Health. 2022;22(1):1676. 10.1186/S12889-022-13918-Y/FIGURES/3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12889-022-13918-Y/FIGURES/3</ArticleId><ArticleId IdType="pmc">PMC9441841</ArticleId><ArticleId IdType="pubmed">36064368</ArticleId></ArticleIdList></Reference><Reference><Citation>Adetifa IMO, Uyoga S, Gitonga JN, et al. : Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya. Nat Commun. 2021;12(1):1&#x2013;6. 10.1038/s41467-021-24062-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24062-3</ArticleId><ArticleId IdType="pmc">PMC8233334</ArticleId><ArticleId IdType="pubmed">34172732</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisale MRO, Ramazanu S, Mwale SE, et al. : Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis. Rev Med Virol. 2022;32(2). 10.1002/RMV.2271</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/RMV.2271</ArticleId><ArticleId IdType="pmc">PMC8420234</ArticleId><ArticleId IdType="pubmed">34228851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, et al. : Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20(1):1&#x2013;23. 10.1186/S12916-021-02228-6/FIGURES/4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12916-021-02228-6/FIGURES/4</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. : Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210-216. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon IS, Li C, Son YM, et al. : Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. 2021;6(65). 10.1126/SCIIMMUNOL.ABK1741</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIIMMUNOL.ABK1741</ArticleId><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto K: Adverse effects of COVID-19 vaccines and measures to prevent them. Virol J. 2022;19(1):1&#x2013;3. 10.1186/S12985-022-01831-0/METRICS</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12985-022-01831-0/METRICS</ArticleId><ArticleId IdType="pmc">PMC9167431</ArticleId><ArticleId IdType="pubmed">35659687</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J, Vogel G. Vaccines may cause rare, Long Covid-like symptoms. Science (1979). 2022;375(6579):364&#x2013;366. 10.1126/SCIENCE.ADA0536</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ADA0536</ArticleId><ArticleId IdType="pubmed">35084966</ArticleId></ArticleIdList></Reference><Reference><Citation>Salcin S, Fontem F: Recurrent SARS-CoV-2 infection resulting in acute respiratory distress syndrome and development of pulmonary hypertension: A case report. Respir Med Case Rep. 2021;33. 10.1016/J.RMCR.2020.101314</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.RMCR.2020.101314</ArticleId><ArticleId IdType="pmc">PMC7718582</ArticleId><ArticleId IdType="pubmed">33312856</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z:Outcomes of SARS-CoV-2 Reinfection. Published online June 17,2022. 10.21203/RS.3.RS-1749502/V1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/RS.3.RS-1749502/V1</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>